Lifestyle modification decreases the mean platelet volume in prehypertensive patients

References

• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr L, Jones DW, Materson BJ, Oparil S, Wright Jr JT, et al. National Heart, Lung, Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study; a cohort study. Lancet 2001; 358: 1682–1686
   PubMed Web of Science ®Google Scholar
• Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287: 10032–10010
   Web of Science ®Google Scholar
• Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291–1297
   PubMed Web of Science ®Google Scholar
• Washio M, Tokunaga S, Yoshimasu K, Kodama H, Liu Y, Sasazuki S, Tanaka K, Kono S, Mohri M, Takeshita A. Role of prehypertension in the development of coronary atherosclerosis in Japan. J Epidemiol 2004; 14: 57–62
   PubMed Web of Science ®Google Scholar
• Liszka HA, Mainous AG, III, King DE, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005; 3: 294–299
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases. Stroke 2005; 36: 1859–1863
   PubMed Web of Science ®Google Scholar
• Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 2006; 48: 254–259
   PubMed Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity?. Clin Appl Thromb Hemost 2003; 9: 177–190
   PubMed Web of Science ®Google Scholar
• Broadley AJ, Gapper P, Schmitt M, Frenneaux MP. Supine rest reduces platelet activation and aggregation. Platelets 2003; 14: 3–7
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002; 13: 301–303
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981–982
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157–161
   PubMed Web of Science ®Google Scholar
• Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications 2004; 18: 173–176
   PubMed Web of Science ®Google Scholar
• Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004; 44: 415–422
   PubMed Web of Science ®Google Scholar
• Yang A, Pizzulli L, Lüderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res. 2006; 117: 371–377
   PubMed Web of Science ®Google Scholar
• Celik T, Yuksel C, Iyisoy A, Kursaklioglu H, Ozcan O, Kilic S, Ozmen N, Isik E. Effects of nebivolol on platelet activation in hypertensive patients: A comparative study with metoprolol. Int J Cardiol 2007; 116: 206–211
   PubMed Web of Science ®Google Scholar
• Blann AD, Nadar S, Lip GYH. Pharmacological modulation of platelet function in hypertension. Hypertension 2003; 42: 1–7
   PubMed Web of Science ®Google Scholar
• Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary Approaches to Prevent and Treat Hypertension. A Scientific Statement From the American Heart Association. Hypertension 2006; 47: 296–308
   PubMed Web of Science ®Google Scholar
• Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus: The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26: 3160–3167
   PubMed Web of Science ®Google Scholar
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438
   PubMed Web of Science ®Google Scholar
• Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: A prospective cohort study. Atherosclerosis 2007; 191: 182–190
   PubMed Web of Science ®Google Scholar
• Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD. Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metab 2001; 86: 5457–5464
   PubMed Web of Science ®Google Scholar
• Onat A, Hergenç G, Türkmen S, Yazıcı M, Sarı I, Can G. Discordance between insulin resistance and metabolic syndrome: Features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006; 55: 445–452
   PubMed Web of Science ®Google Scholar
• Toplak H, Wascher TC. Cardiovascular risk factors in obesity. Influence of weight reduction on platelet volume: Different effects of hypocaloric diet and a very low calorie diet. Eur J Clin Invest 1994; 24: 778–780
   PubMed Web of Science ®Google Scholar
• Roemmich JN, Liu EY, Rogol AD, Epstein LH, Quattrin T. Diminished insulin resistance with weight loss in severely overweight youth. Metab Syndr Relat Disord 2004; 2: 160–168
   PubMed Web of Science ®Google Scholar
• Tavil Y, Sen N, Yazıcı HU, Hızal F, Abacı A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thrombosis Research 2007; 120: 245–250
   PubMed Web of Science ®Google Scholar
• Muscari A, De Pascalis S, Cenni A, Ludovico C, Castaldini N, Antonelli S, Bianchi G, Magalotti D, Zoli M. Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008; 99: 1079–1084
   PubMed Web of Science ®Google Scholar
• El-Sayed MS. Exercise training effects on platelets in health and disease. Platelets 2002; 13: 261–266
   PubMed Web of Science ®Google Scholar
• Ahmadizad S, El-Sayed MS. The Effects of Graded Resistance Exercise on Platelet Aggregation and Activation. Med Sci Sports Exerc 2003; 32: 1026–1032
   Google Scholar
• Rauramaa R, Salonen JT, Seppanen K. Inhibition of platelet aggregability by moderate intensity physical exercise: A randomised clinical trial in overweight men. Circulation 1986; 74: 939–944
   PubMed Web of Science ®Google Scholar
• Onat A, Yazici M, Can G, Kaya Z, Bulur S, Hergenç G. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among turks. Am J Hypertens 2008; 21: 890–895
   PubMed Web of Science ®Google Scholar
• Haubelt H, Simon M, Anders Ch, Hellstern P. Platelet function tests for monitoring of acetylsalicylic acid: Clinical significance in antiplatelet treatment. Hamostaseologie 2004; 24: 196–202
   PubMedGoogle Scholar